Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine for postoperative analgesia after cesarean section
ChiCTR2400088013Phase 4Not yet recruiting
- Sponsor
- The First Hospital of Lanzhou University
- Start
- Aug 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by The First Hospital of Lanzhou University. Primary endpoints: Difference of NRS pain scores at rest and during movement within 24 hours after anesthesia and Difference in number of PCA compressions within 24 hours after anesthesia. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400088013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088013.